Compare AZN & MUFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AZN | MUFG |
|---|---|---|
| Founded | 1992 | 1880 |
| Country | United Kingdom | Japan |
| Employees | 96100 | 178953 |
| Industry | Biotechnology: Pharmaceutical Preparations | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.4B | 234.0B |
| IPO Year | N/A | N/A |
| Metric | AZN | MUFG |
|---|---|---|
| Price | $183.09 | $19.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.9M | ★ 3.2M |
| Earning Date | 04-29-2026 | 05-15-2026 |
| Dividend Yield | 1.73% | ★ 2.32% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.34 | $4.62 |
| Revenue Next Year | $6.43 | $10.12 |
| P/E Ratio | $31.91 | ★ $25.47 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $68.62 | $13.20 |
| 52 Week High | $212.71 | $21.18 |
| Indicator | AZN | MUFG |
|---|---|---|
| Relative Strength Index (RSI) | 52.86 | 51.54 |
| Support Level | $180.98 | $19.57 |
| Resistance Level | $191.50 | $20.19 |
| Average True Range (ATR) | 2.98 | 0.32 |
| MACD | 0.42 | -0.04 |
| Stochastic Oscillator | 80.83 | 14.59 |
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Mitsubishi UFJ Financial Group is the largest bank in Japan in terms of market capitalization and assets. It is the largest non-Chinese bank group globally and has a balance sheet slightly larger than those of JPMorgan Chase and HSBC Holdings. MUFG's operations in Japan account for around half of profit, banking in Thailand and Indonesia for around 15%, and equity-method earnings from Morgan Stanley most of the rest.